Founded in 1994, Euroscreen SA is a clinical-stage, privately-held biotechnology company based in Belgium. Our mission is to invent and develop small-molecule drug candidates to valuable endpoints for licensing/partnering with pharmaceutical companies. Euroscreen's competitive advantage comes from our focus on GPCRs drug targets and the proven efficiency of our integrated research team to deliver innovative drug candidates through to preclinical or early clinical endpoints attractive to big pharma partners.
Location: Belgium
Member count: 11-50
Founded date: 1994
Investors 2
| Date | Name | Website |
| - | Theodorus | theodorus.... |
| - | Capricorn ... | capricorn.... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 03.04.2017 | Astellas ... | Astellas Pharma’s Illinois ... | - | Arsalan Ar... | endpts.com... |
| 03.04.2017 | Term Sheet... | BIG DEAL Hello. Just about ev... | - | - | fortune.co... |
| 02.04.2017 | Astellas t... | Tokyo, Japan, and Gosselies, B... | - | - | capricorn.... |
| 02.04.2017 | Astellas t... | Tokyo, Japan, and Gosselies, B... | - | - | capricorn.... |
| 20.12.2016 | Ogeda anno... | Gosselies, Belgium: 20 Decembe... | - | - | capricorn.... |